Defining high-risk LUAD subtypes with large-scale RWD

RWD analysis identifies six LUAD subtypes, including a high-risk group with poor outcomes

INDICATION
Lung

The molecular C5 subtype exhibits the poorest prognosis among LUAD patients

 

 

(a) Kaplan-Meier survival curves showing rwPFS from the start of index treatment (metastatic line of therapy [LOT] 1) to the first progression event. (b) Distribution of LOT1 therapy groups across LUAD subtypes. (c) Forest plot showing multivariate CoxPH analysis, controlling for clinical confounders.

 

Related cases

Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Grid displaying data points with blue, black, and gray squares on a white background.

RB1 loss-of-function mutations in post-Osimertinib NSCLC and prognostic implications

2026-07-01
Lung
RB1
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Abstract grid of small blue, gray, black, and orange squares on a white background.

Tracking PPM1D post-treatment prevalence to evaluate prognosis in lung adenocarcinoma

2026-07-01
Lung
PPM1D
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Pixelated diagonal gradient with bands of purple, blue, and green dots, resembling data visualization.

PRAME expression and histology impact survival in first-line NSCLC

2026-05-26
Lung
PRAME